Sound Source Localization Testing in Single-sided Deafness Following Bone Conduction Intervention
December 20th, 2024
We present a protocol to evaluate the impact of bone conduction intervention on sound localization ability in patients with single-sided deafness (SSD). This protocol can be applied to assess the efficacy of bone conduction devices in restoring sound localization abilities and improving the overall quality of life for individuals with SSD.
We study whether bone conduction hearing aids improve sound localization in single-sided deafness, and if so, how much improvement they provide for communication and navigation. The most recent developments in our field include advancements in bone conduction technology, offer you more options and improve the sound quality for individuals with hearing loss. Current technologies used to advance research in our field include sound treated rooms, specialized software for testing sound localization, and the bone conduction hearing aids. A key challenge is ensuring participants understand the task, give a cured response, and remain comfortable while returning appropriate sound levels. Bone conduction hearing is improved sound localization in single-sided deafness, so the degree varies. Overall, they shown promise in addressing related channels.
[Instructor] To begin, ensure that a Windows personal computer with a compatible audio driver and a multi-channel sound card is available. Then using balanced cables, connect actively powered speakers to the sound card. Configure the audio hardware, following the manufacturer's instructions to ensure glitch-free playback and adequate channel separation. Then position the speakers in a circular setup, ensuring the subject is placed in the center of the semicircle, facing the frontal loudspeaker. For calibration, choose the appropriate audio driver in the software. Select the ASIO compatible sound card from the list of available devices. Review and configure the necessary parameters in the setup menu. Then review the driver settings of the sound device. To start the calibration procedure, click Extras, followed by Calibrate in the software. Verify the loudspeaker to sound card channel output mapping. Then assign response-only dummy speakers to channel zero. Click on a speaker button in the software to play the calibration noise for 10 seconds on the selected loudspeaker. Next, using the sound pressure level meter, measure the sound pressure level at the virtual head position of the test subject, pointing the meter tip towards the active speaker. Adjust the loudspeaker and system gains to achieve a noise level of approximately 70 decibels A-weighted, allowing a range of 67 to 75 decibels A-weighted. Click on the Done button in the software to complete the calibration process. Now click the Calibration Verification button in the software to validate the setup. Specify metadata in the software. During the calibration, assign any response-only dummy speakers to channel zero. Choose the study folder where the experiment results will be saved. Then click the start button in the software to begin the experiment. View the experiment results in real time using the live mode, or after the experiment is completed using the final mode. Finally, perform batch analysis of all MAT files in the study folder and export confusion matrices as PNG images. Without bone conduction device intervention, the child with left-sided deafness demonstrated a significant right word localization bias and poor localization accuracy. With bone conduction device intervention on the right side, the child's localization bias was reduced to some extent, and localization accuracy also improved.
Overview
This study evaluates the impact of bone conduction hearing aids on sound localization abilities in patients with single-sided deafness (SSD). The protocol aims to assess the efficacy of these devices in enhancing communication and navigation for individuals with SSD.
Key Study Components
Area of Science
- Neuroscience
- Auditory Rehabilitation
- Hearing Technology
Background
- Single-sided deafness (SSD) presents unique challenges in sound localization.
- Bone conduction technology has advanced, providing new options for individuals with hearing loss.
- Understanding sound localization is crucial for effective communication and navigation.
- Current research utilizes specialized software and sound-treated environments for testing.
Purpose of Study
- To determine if bone conduction hearing aids improve sound localization in SSD patients.
- To assess the degree of improvement in communication and navigation abilities.
- To evaluate the overall quality of life for individuals using these devices.
Methods Used
- Participants are tested in a controlled sound-treated room.
- Bone conduction devices are calibrated for optimal sound delivery.
- Sound localization tasks are administered to evaluate performance.
- Data is analyzed to measure improvements in localization accuracy.
Main Results
- Bone conduction devices showed promise in improving sound localization.
- Participants demonstrated reduced localization bias with device intervention.
- Localization accuracy improved significantly in tested subjects.
- Results indicate potential benefits for communication and navigation.
Conclusions
- Bone conduction hearing aids can enhance sound localization in SSD patients.
- Improvements in localization accuracy may lead to better quality of life.
- Further research is needed to optimize these interventions.
Frequently Asked Questions
Executive Industry Relevance
Sound source localization testing in single-sided deafness (SSD) following bone conduction intervention addresses a critical challenge in auditory device development: restoring spatial hearing in patients with unilateral loss. Quantitative localization metrics, such as root mean square error and bias, provide objective endpoints for evaluating device impact and guiding R&D decisions. This protocol supports predictive confidence in device efficacy and informs portfolio strategies for hearing technology innovation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables objective assessment of auditory pathway function post-intervention.
- Supports mechanistic de-risking by quantifying localization improvements attributable to device use.
- Provides functional validation data for candidate hearing technologies.
Screening & Assay Development
- Establishes standardized, reproducible localization assays using controlled sound environments and calibrated hardware.
- Generates quantitative outputs (RMSE, bias) suitable for cross-device and cross-cohort comparisons.
- Facilitates screening of device configurations for optimal spatial hearing restoration.
Translational & Preclinical Research
- Aligns preclinical device testing with clinically relevant auditory endpoints.
- Supports continuity from bench to bedside by mirroring real-world localization challenges.
- Enables risk-adjusted advancement of device candidates based on functional performance data.
Pipeline & Workflow Integration
This protocol integrates into the device development continuum from early discovery through preclinical validation, providing a bridge between engineering innovation and functional outcome assessment.
- Discovery Biology: Quantifies auditory system response to bone conduction intervention, supporting hypothesis testing on spatial hearing restoration.
- Screening: Delivers reproducible, quantitative localization metrics for device evaluation.
- Analytics: Provides statistical outputs (RMSE, bias) for robust comparison of intervention effects.
- Translational Research: Connects device performance in controlled settings to anticipated clinical benefit.
- Enterprise Reuse: Offers a standardized testing framework adaptable across device platforms and patient populations.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in device-mediated spatial hearing outcomes.
- Operational Value: Promotes assay standardization, reproducibility, and scalability for device testing.
- Strategic Value: Informs go/no-go decisions and portfolio prioritization based on quantitative functional endpoints.
- Portfolio Impact: Supports risk-adjusted advancement and cross-platform benchmarking of hearing technologies.
Implementation Considerations
- Requires expertise in auditory neuroscience and device calibration.
- Demands access to sound-treated rooms, multi-channel audio hardware, and specialized analysis software.
- Necessitates rigorous cross-team standardization of testing protocols and data analysis.
- Adaptable to various device types and patient demographics with appropriate calibration.
- Dependent on participant compliance and accurate response collection for reliable data.
